Qingyu Wu

Since joining Kirkland & Ellis, Qingyu has been involved in the following representations: 

• Zhejiang Galaxis Technology Group Co., Ltd. (HKSE: 2729) on its HK$610 million global offering and listing on the Main Board of the Hong Kong Stock Exchange on March 24, 2026
• The joint sponsors, Morgan Stanley Asia Limited, CITIC Securities (Hong Kong) Limited and Goldman Sachs (Asia) L.L.C., and underwriters on the HK$10.68 billion initial public offering and listing of Muyuan Foods Co., Ltd. (SZ: 002714; HKSE: 2714) on the Main Board of the Hong Kong Stock Exchange on February 6, 2026
• The joint sponsors, UBS Securities Hong Kong Limited, China International Capital Corporation Hong Kong, Ping An of China Capital (Hong Kong) Company Limited and GF Capital (Hong Kong) Limited, and underwriters on the HK$4.8 billion global offering and listing of OmniVision Integrated Circuits Group, Inc. (SH: 603501; HKSE: 0501), a global fabless semiconductor design company, on the Main Board of the Hong Kong Stock Exchange
• The sole sponsor, Huatai Financial Holdings (Hong Kong) Limited, and the underwriters on the global offering and listing of Shanghai Iluvatar CoreX Semiconductor Co., Ltd. (HKSE: 9903) on the Hong Kong Stock Exchange, responsible for drafting the prospectus. Iluvatar CoreX is a leading player in China’s general-purpose GPU industry
• Wynn Macau (HKSE:1128) in its offering of US$1 billion of 6.750% senior notes due 2034 

Prior to joining Kirkland & Ellis, Qingyu represented clients in the following selected transactions:

• SICC Co., Ltd. on its USD 260 million initial public offering and listing on the Main Board of the Hong Kong Stock Exchange
• Zhejiang Sanhua Intelligent Controls Co., Ltd. on its USD 1.19 billion initial public offering and listing on the Main Board of the Hong Kong Stock Exchange. 
• Shanghai Forest Cabin Biological-Tech Co., Ltd. on its HKD 1 billion initial public offering and listing on the Main Board of the Hong Kong Stock Exchange
• China Resources Beverages on its USD 650 million initial public offering and listing on the Main Board of the Hong Kong Stock Exchange
• Deepexi Technology Co., Ltd. on its HKD 710 million initial public offering and listing on the Main Board of the Hong Kong Stock Exchange
• Auntea Jenny on its HKD 273 million initial public offering and listing on the Main Board of the Hong Kong Stock Exchange
• Weilong Delicious on its USD 140 million initial public offering and listing on the Main Board of the Hong Kong Stock Exchange. 
• Guoquan Food (Shanghai) Co., Ltd. on its USD 53 million initial public offering and listing on the Main Board of the Hong Kong Stock Exchange
• Shiyue Daotian Group Co., Ltd. on its USD 105 million initial public offering and listing on the Main Board of the Hong Kong Stock Exchange
• Shanghai Chicmax Cosmetic Co., Ltd. on its USD 141.5 million initial public offering and listing on the Main board of the Hong Kong Stock Exchange. 
• Xiaocaiyuan International Holding Limited on its USD 110 million initial public offering and listing on the Main Board of the Hong Kong Stock Exchange
• Chenqi Technology Limited on its USD 134 million initial public offering and listing on the Main Board of the Hong Kong Stock Exchange
• Shanghai Able Digital Science &Tech Co., Ltd. on its initial public offering and listing on the Main Board of the Hong Kong Stock Exchange
• Goldman Sachs and Huatai Financial as the joint sponsors as well as the underwriters on Bloks Group Limited’s USD 187 million initial public offering and listing on the Main Board of the Hong Kong Stock Exchange
• Marketingforce Management Ltd on its USD 33 million initial public offering and listing on the Main Board of the Hong Kong Stock Exchange
• JF Wealth on its USD 142 million initial public offering and listing on the Main Board of the Hong Kong Stock Exchange. 
• Morgan Stanley, Haitong International, and Huatai Financial Holdings as the joint sponsors on Beauty Farm Medical and Health Industry Inc’s initial public offering and listing on the Main Board of the Hong Kong Stock Exchange. 
• The sponsors and the underwriters on Medbanks’ initial public offering and listing on the Main Board of the Hong Kong Stock Exchange. 
• Dingdang Health Technology Group Ltd. on its USD 51.23 million initial public offering and listing on the Main Board of the Hong Kong Stock Exchange. 
• The sponsors and the underwriters on Hongjiu Fruit’s initial public offering and listing on the Main Board of the Hong Kong Stock Exchange. 
• Huaxin Cement Co., Ltd. on its B to H Shares listing by way of introduction on the Main Board of the Hong Kong Stock Exchange. 
• UNQ Holdings Limited. on its USD 46.86 million initial public offering and listing on the Main Board of the Hong Kong Stock Exchange.
• Goldman Sachs and CICC as the joint sponsors as well as the underwriters on Angelalign Technology Inc.’s initial public offering and listing on the Main Board of the Hong Kong Stock Exchange. 
• XD Inc. on its USD 105 million initial public offering and listing on the Main Board of the Hong Kong Stock Exchange. 
• The sponsors and the underwriters on Kunming Dianchi Water Treatment Co., Ltd.’s initial public offering and listing on the Main Board of the Hong Kong Stock Exchange. 
• The sponsors and the underwriters on Postal Savings Bank of China’s initial public offering and listing on the Main Board of the Hong Kong Stock Exchange. 
• Ningbo Shanshan Co., Ltd. on its offering of global depositary receipts  (GDRs) on SIX Swiss Exchange
• GEM Co., Ltd. on its offering of global depositary receipts  (GDRs) on SIX Swiss Exchange